It has been about a month since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have added about 6.5% in that time frame, outperforming the S&P 500. But investors have to be ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Marvel Rivals Season 5.5 launched on December 12, bringing Rogue as a brand new Vanguard. The iconic mutant has been heavily requested ever since Marvel Rivals launched, and now players will be able ...

If you're interested in exploring more stocks under $5 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Searching for quality stocks under $5 is a lot ...

Credit Human Share Certificates made our list of the best five-year CD accounts thanks to its competitive APY and relatively low minimum deposit requirement. We like that Credit Human Share ...